Anne Kever


Scientist, Keenan Research Centre for Biomedical Science


Anne Kever is a research scientist at the Keenan Research Centre for Biomedical Science (KRCBS) and the Barlo Multiple Sclerosis Centre. She obtained her Master and PhD in cognitive psychology from the Université catholique de Louvain in Belgium. She is also a trained clinical psychologist specialized in cognitive-behavioral therapy. During a 3-year postdoc at the Columbia University Irving Medical Center, she acquired extensive knowledge in the field of Multiple Sclerosis (MS). Her primary research focus lies in understanding implications of psychosocial and cognitive factors for physical and mental health in clinical populations, particularly persons MS. She also recently developed a research program examining the role of cognitive biases in chronic, MS-related pain. Her goal is to use empirical methods to design targeted, evidence-based treatments to reduce disease-burden and improve quality of life in patients dealing with chronic (neurological) conditions. Despite her short career, she has published over 15 papers as first-author in international, peer-reviewed journals and regularly acts as reviewer for different scientific journals.

Recent Publications

  1. Kever, A, Aguerre, IM, Vargas, W, Straus Farber, R, Levine, L, Riley, CS et al.. Feasibility trial of a telehealth support group intervention to reduce anxiety in multiple sclerosis. Clin Rehabil. 2022;36 (10):1305-1313. doi: 10.1177/02692155221107077. PubMed PMID:35673256 .
  2. Kever, A, Walker, ELS, Riley, CS, Heyman, RA, Xia, Z, Leavitt, VM et al.. Association of personality traits with physical function, cognition, and mood in multiple sclerosis. Mult Scler Relat Disord. 2022;59 :103648. doi: 10.1016/j.msard.2022.103648. PubMed PMID:35134623 PubMed Central PMC8986589.
  3. Leavitt, VM, Kever, A. It's time to talk about disclosure and concealment in MS. Mult Scler Relat Disord. 2022;58 :103537. doi: 10.1016/j.msard.2022.103537. PubMed PMID:35066274 .
  4. Kever, A, Riley, CS, Leavitt, VM. Diagnosis concealment is associated with psychosocial outcomes in persons with multiple sclerosis. Mult Scler. 2022;28 (8):1311-1314. doi: 10.1177/13524585211070496. PubMed PMID:35034518 .
  5. Kever, A, Leavitt, VM. Assessing diagnosis disclosure and concealment in multiple sclerosis: Development and initial validation of the DISCO-MS survey. Mult Scler. 2022;28 (2):247-256. doi: 10.1177/13524585211037581. PubMed PMID:34498517 .
  6. Kever, A, Geers, L, Carr, EW, Vermeulen, N, Grynberg, D, Winkielman, P et al.. When the body matches the picture: The influence of physiological arousal on subjective familiarity of novel stimuli. J Exp Psychol Hum Percept Perform. 2021;47 (6):759-764. doi: 10.1037/xhp0000922. PubMed PMID:34383541 .
  7. Kever, A, Buyukturkoglu, K, Levin, SN, Riley, CS, De Jager, P, Leavitt, VM et al.. Associations of social network structure with cognition and amygdala volume in multiple sclerosis: An exploratory investigation. Mult Scler. 2022;28 (2):228-236. doi: 10.1177/13524585211018349. PubMed PMID:34037495 .
  8. Kever, A, Buyukturkoglu, K, Riley, CS, De Jager, PL, Leavitt, VM. Social support is linked to mental health, quality of life, and motor function in multiple sclerosis. J Neurol. 2021;268 (5):1827-1836. doi: 10.1007/s00415-020-10330-7. PubMed PMID:33392637 .
  9. Leavitt, VM, Kever, A. Psychological resilience explains functional variability across people with multiple sclerosis - Yes. Mult Scler. 2021;27 (4):503-504. doi: 10.1177/1352458520972263. PubMed PMID:33332215 .
  10. Kever, A, Nelson, KE, Aguerre, IM, Riley, CS, Boehme, A, Lee, NW et al.. ASPIRE trial: study protocol for a double-blind randomised controlled trial of aspirin for overheating during exercise in multiple sclerosis. BMJ Open. 2020;10 (11):e039691. doi: 10.1136/bmjopen-2020-039691. PubMed PMID:33191260 PubMed Central PMC7668379.
Search PubMed